Prophylactic Penehyclidine Hydrochloride Inhalation and 3-year Outcome After Surgery
Impact of Prophylactic Penehyclidine Hydrochloride Inhalation on Long-term Outcome in High-risk Patients: 3-year Follow-up of a Randomized Controlled Trial
Sponsor: Peking University First Hospital
Listed as NCT03868709, this PHASE4 trial focuses on Long-term Outcome and Postoperative Complications and remains completed. Sponsored by Peking University First Hospital, it has been updated 7 times since 2019, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
7 versions recorded-
May 2025 — Present [monthly]
Completed PHASE4
-
Sep 2024 — May 2025 [monthly]
Completed PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE4
-
May 2022 — Jul 2024 [monthly]
Completed PHASE4
Status: Active Not Recruiting → Completed
-
Feb 2021 — May 2022 [monthly]
Active Not Recruiting PHASE4
▶ Show 2 earlier versions
-
Jan 2021 — Feb 2021 [monthly]
Active Not Recruiting PHASE4
-
Apr 2019 — Jan 2021 [monthly]
Active Not Recruiting PHASE4
First recorded
Mar 2019
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Peking University First Hospital
For direct contact, visit the study record on ClinicalTrials.gov .